Scientists at Yale University investigating the mechanisms at play in type-2 diabetes have discovered a new way they may be able to apply the brakes to the condition. The breakthrough centers on a new understanding of how fasting can drive the onset of type-2 diabetes, which led the researchers to unearth a way of intervening and switching the process off.
The best way to fight off cancer might be to strengthen the body’s immune system and help it identify and kill tumors. This field of study is known as immunotherapy, and while it’s showing promise it can be quite expensive. Now, researchers at the University of Wisconsin-Madison have developed artificial nanoparticles that should be cheaper and easier to produce.
A newly published article in the Journal of Medical Virology is reporting the first results of a genetic study into the DNA of the novel coronavirus currently spreading across the globe. The research suggests the new virus may have originated in snakes, which were known to be sold at the animal market in Wuhan where the outbreak began.
A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”
New results have been published from one of the first placebo-controlled clinical trials investigating the effects of microdosing Lysergic Acid Diethylamide (LSD). This Phase 1 trial is the first step in testing whether these kinds of psychedelic microdose methods could be useful as a therapeutic approach for treating Alzheimer’s disease, and while the early data doesn’t identify significant cognitive benefits in microdosing, it certainly demonstrates the method is safe enough to proceed to larger efficacy trials.
Theft has been a major issue involved in the ever-growing opioid crisis in America. People are legally prescribed opioid painkillers by their physicians, and find, very often, that they become addicted.
Well, they often can’t return to their doctor for another prescription, so are they forced to hit the streets in search of their next fix. However, the drugs aren’t free, and many who become dependent quickly realize they can’t afford to keep using. But the drug has taken hold and many cannot stop.
So they begin to sell their own possessions – until they run out. Then the now addicts turn to crime – to theft. And many times, the brick and mortar retail store pays the price of that theft.
from Zero Hedge:
“Happening Everywhere In Retail” – Home Depot Links Surge In Thefts To Opioid Crisis
The opioid crisis is evolving and is now becoming a burden on retailers, as addicts race to brick and mortar stores, hoping to steal merchandise, and if successful, sell it on the street or pawn it for cash to pay for their next fix.
Two compelling new studies are building on a hypothesis suggesting age-related dementia is caused by a leaky blood-brain barrier, triggering neuro-inflammation and, ultimately, brain cell damage. The research reveals a novel anti-inflammatory drug can reverse brain aging in senile mice, but experts suggest the studies are interesting but not particularly applicable to human cases of dementia.
from Brent Smith for World Net Daily:
There are some odd things going on in our country lately.
Yes, I know that’s a silly open-ended statement and could refer to just about anything these days. But I’m talking about the seeming disconnect between states and the federal government. Or more specifically, the disconnect between state and federal laws.
In this case, the disconnect between federal marijuana laws and that of the states.
Marijuana is considered an illegal substance by the feds, yet at least 11 states have legalized its purchase and consumption – either strictly medically and/or for recreational use.
The United States Constitution is unmistakably clear concerning the relationship of federal and state law.